12/17/2024
8:30 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:06 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
8:45 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
5:09 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:37 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/16/2024
3:05 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
5:04 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:30 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
8:39 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
10:23 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:19 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
5:20 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:39 PM | Fink Jeffrey Arvin (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:41 PM | Higuchi John W. (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:43 PM | Jene Jill M. (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:45 PM | Lipocine (Issuer)
Ono Richard Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:48 PM | Lipocine (Issuer)
Papapetropoulos Spyros (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:32 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
4:15 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:03 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:06 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
5:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Lipocine (Filer)
| Form 424B5 | |
04/26/2024
4:20 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
11:15 PM | Lipocine (Filer)
| Form EFFECT | |
04/23/2024
3:24 PM | Lipocine (Filer)
| Form S-3/A | |
04/23/2024
3:05 PM | Lipocine (Filer)
| Form DEF 14A | |
04/11/2024
6:24 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
5:26 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
5:14 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
4:51 PM | Fogarty Krista (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Kamala’s final humiliation (Ad) The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware of… yet have the potential to deliver colossal returns over the next four years.
I’m not talking about Tesla, Palantir, or anything else you’ve heard parroted by the mainstream financial press. No. These are Trump’s Secret Stocks.  It’s all waiting for you here. |
03/12/2024
4:53 PM | Lipocine (Issuer)
Patel Mahesh V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:31 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:07 AM | Lipocine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
5:08 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:01 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:20 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
